Global Newborn Screening Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global newborn screening market in its upcoming report titled, “Global Newborn Screening Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global newborn screening market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global newborn screening market report has been segmented on the basis of product, technology, test type, and region.

Request Covid - 19 Impact

Newborn screening is a simple and safe test which is performed in 48 to 72 hours after the birth of baby. The test requires few drops of blood and a simple hearing test. Newborn screening tests is a practice of testing every newborn for potentially fatal and harmful disorders. It detects hidden medical condition which may later cause serious illness and hamper the growth of the child. Newborn screening allows detection and early treatment that helps the baby to live a normal life. The test identifies the disorders such as phenylketonuria, galactosemia, sickle cell disease, congenital hypothyroidism, tyrosinemia etc.

Raising awareness regarding the benefits associated with newborn screening is expected to drive the global newborn screening market over the forecast period. In addition, continuous innovation in newborn screening tests is further expected to propel the market growth over the forecast period. Moreover, increasing funding from the government organization to promote newborn screening, in turn, is expected to boost the growth of global newborn screening market over the forecast period.

However, lack of trained professional and lack of technologically advanced instruments for testing are major factors expected to restrain the market growth over the forecast period.

North America market dominates the global newborn screening market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the developed healthcare infrastructure, favorable government initiatives, and introduction of new test methods in the region. Europe accounts for second-largest revenue share contribution to the global newborn screening market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. Factors such as rising awareness regarding newborn diseases, improving healthcare infrastructure, and the higher birth rate is expected to drive the market in the region.

c

Global newborn screening market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa